Company Name: Sangamo BioSciences, Inc.
Sangamo BioSciences, Inc. is a clinical stage biopharmaceutical company. The company is engaged in the development of engineered zinc finger DNA-binding proteins and is developing therapeutics for monogenic and infectious diseases using its proprietary ZFP technology platform.
Ticker Symbol: SGMO (NASDAQ)
Company Website: www.sangamo.com
Social Media: Sangamo BioSciences LinkedIn
Headquarters: Richmond, CA